Safety

Safety

Patient Safety

Starting from the identification of a potential new medication, we aim to consistently monitor and ensure a thorough understanding of its benefits and risks among regulators, healthcare providers, and patients.
FRONS adopts a comprehensive and rigorous pharmacovigilance strategy aimed at assessing and upholding the benefit-risk profile of its products. In instances of significant safety concerns, FRONS promptly communicates these issues to healthcare practitioners, patients, and regulatory bodies.
FRONS is committed to supporting patients in effectively managing their medications and is eager to share its approach in fulfilling its dedication to patient safety.

Before introducing its products to the public for patient use, FRONS conducts a comprehensive safety assessment of trademarks. Additionally, we conduct a meticulous search across multiple relevant databases of product names to identify any potential look-alike or sound-alike similarities that could cause confusion and lead to medication errors.
FRONS employs well-established methodologies developed by reputable companies dedicated to patient safety to carry out these assessments.